top of page

Sackler Family Risks Litigation After Supreme Court Rejects Purdue Pharma Settlement

  • Ann Tucker
  • Jul 9, 2024
  • 1 min read

Forbes [7/09]  -  Purdue Pharma went back to court this week after the Supreme Court thwarted the OxyContin maker’s multibillion-dollar bankruptcy settlement, which would have shielded members of the Sackler family from civil liability for their role in the opioid crisis—and the billionaire family stands to face fresh litigation if the parties can’t figure out a new settlement.


The Supreme Court recently rejected Purdue Pharma’s bankruptcy settlement with the thousands of individuals, states and other entities who sued the company and some of the Sacklers for their role in perpetuating the opioid epidemic, striking down a provision in the deal that would have allowed the Sacklers to pay $6 billion in exchange for not facing any more civil lawsuits going forward. CONT

Recent Posts

See All

Comments


Subscribe to the CLASPP Newsletter

Our members and supporters stay informed. From state and federal policy news to training and webinar events, funding opportunities and more, CLASPP brings it to you first.

Thanks for submitting!

© 2022 by CLASPP

bottom of page